Tekla Life Sciences Investors (HQL)
Company Info
Highlights
$346.56M
$3.00
4.06
$1.91M
$1.91M
$10.19 - $14.14
0.18
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
Loading data...
Returns By Period
Tekla Life Sciences Investors (HQL) returned 1.85% year-to-date (YTD) and 9.54% over the past 12 months. Over the past 10 years, HQL returned 1.87% annually, underperforming the S&P 500 benchmark at 10.84%.
HQL
1.85%
2.72%
-5.43%
9.54%
5.76%
3.14%
1.87%
^GSPC (Benchmark)
0.52%
6.32%
-1.44%
12.25%
12.45%
14.20%
10.84%
Monthly Returns
The table below presents the monthly returns of HQL, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 8.31% | -2.20% | -5.58% | 1.10% | 0.72% | 1.85% | |||||||
| 2024 | 1.93% | 2.62% | -0.44% | -4.03% | 5.44% | 6.38% | 8.47% | 1.62% | -0.33% | -3.45% | 1.49% | -7.99% | 11.03% |
| 2023 | 5.14% | -4.36% | -0.22% | 0.00% | -2.34% | 1.88% | -0.67% | -0.91% | -4.15% | -7.06% | 5.71% | 12.64% | 4.23% |
| 2022 | -5.62% | -7.06% | 0.42% | -6.35% | -3.63% | -2.33% | 4.85% | -1.25% | -5.40% | 7.25% | 5.11% | -5.77% | -19.21% |
| 2021 | 2.78% | 4.98% | -5.65% | 4.01% | -0.76% | 7.58% | -2.98% | 7.08% | -4.81% | 2.26% | -4.77% | -3.07% | 5.52% |
| 2020 | -5.05% | -1.82% | -5.67% | 13.75% | 6.48% | 0.90% | -0.28% | 1.89% | -1.40% | -3.87% | 13.07% | 5.72% | 23.72% |
| 2019 | 15.69% | 2.24% | -2.34% | -4.14% | -3.13% | 8.43% | -2.61% | -3.24% | -2.64% | 5.23% | 9.95% | 1.69% | 25.53% |
| 2018 | 4.13% | -3.82% | -0.26% | -3.33% | 3.07% | 0.21% | 4.52% | 6.37% | -0.29% | -13.17% | 2.21% | -14.58% | -16.18% |
| 2017 | 5.18% | 7.17% | 3.25% | 5.72% | -1.61% | 5.52% | 3.41% | 2.80% | -1.10% | -5.31% | -4.92% | 3.81% | 25.51% |
| 2016 | -23.18% | -3.88% | 5.65% | 3.98% | 4.81% | -6.24% | 10.94% | -2.20% | 0.43% | -10.57% | 7.60% | -3.63% | -19.46% |
| 2015 | 8.64% | 5.81% | -1.89% | -4.32% | 7.08% | 1.80% | 5.85% | -8.34% | -15.82% | 15.77% | -0.66% | -4.28% | 5.77% |
| 2014 | 3.87% | 16.77% | -10.75% | -4.41% | -0.09% | 1.91% | 1.83% | 8.45% | -1.69% | 9.19% | 5.88% | -0.72% | 31.29% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of HQL is 58, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Tekla Life Sciences Investors (HQL) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Loading data...
Dividends
Dividend History
Tekla Life Sciences Investors provided a 15.14% dividend yield over the last twelve months, with an annual payout of $1.89 per share.
| Period | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $1.89 | $1.86 | $1.27 | $1.36 | $1.69 | $1.56 | $1.40 | $1.62 | $1.62 | $2.07 | $2.80 | $1.77 |
Dividend yield | 15.14% | 14.18% | 9.44% | 9.57% | 8.79% | 7.90% | 8.03% | 10.72% | 8.25% | 12.18% | 11.84% | 7.11% |
Monthly Dividends
The table displays the monthly dividend distributions for Tekla Life Sciences Investors. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | $0.00 | $0.47 | $0.00 | $0.00 | $0.43 | $0.90 | |||||||
| 2024 | $0.00 | $0.39 | $0.00 | $0.00 | $0.48 | $0.00 | $0.00 | $0.49 | $0.00 | $0.00 | $0.50 | $0.00 | $1.86 |
| 2023 | $0.00 | $0.33 | $0.00 | $0.00 | $0.32 | $0.00 | $0.00 | $0.32 | $0.00 | $0.00 | $0.30 | $0.00 | $1.27 |
| 2022 | $0.00 | $0.39 | $0.00 | $0.00 | $0.35 | $0.00 | $0.00 | $0.31 | $0.00 | $0.00 | $0.31 | $0.00 | $1.36 |
| 2021 | $0.00 | $0.43 | $0.00 | $0.00 | $0.41 | $0.00 | $0.00 | $0.43 | $0.00 | $0.00 | $0.42 | $0.00 | $1.69 |
| 2020 | $0.00 | $0.39 | $0.00 | $0.00 | $0.34 | $0.00 | $0.00 | $0.41 | $0.00 | $0.00 | $0.40 | $0.02 | $1.56 |
| 2019 | $0.00 | $0.33 | $0.00 | $0.00 | $0.37 | $0.00 | $0.00 | $0.37 | $0.00 | $0.00 | $0.33 | $0.00 | $1.40 |
| 2018 | $0.00 | $0.40 | $0.00 | $0.00 | $0.40 | $0.00 | $0.00 | $0.40 | $0.00 | $0.00 | $0.42 | $0.00 | $1.62 |
| 2017 | $0.00 | $0.36 | $0.00 | $0.00 | $0.41 | $0.00 | $0.00 | $0.42 | $0.00 | $0.00 | $0.43 | $0.00 | $1.62 |
| 2016 | $0.00 | $0.48 | $0.00 | $0.37 | $0.00 | $0.82 | $0.00 | $0.00 | $0.00 | $0.00 | $0.40 | $0.00 | $2.07 |
| 2015 | $0.00 | $0.50 | $0.00 | $0.00 | $0.54 | $0.00 | $0.00 | $0.58 | $0.00 | $0.00 | $0.47 | $0.71 | $2.80 |
| 2014 | $0.42 | $0.00 | $0.00 | $0.43 | $0.00 | $0.00 | $0.45 | $0.00 | $0.00 | $0.47 | $0.00 | $1.77 |
Dividend Yield & Payout
Dividend Yield
Tekla Life Sciences Investors has a dividend yield of 15.14%, which means its dividend payment is significantly above the market average.
Payout Ratio
Tekla Life Sciences Investors has a payout ratio of 54.61%, which is quite average when compared to the overall market. This suggests that Tekla Life Sciences Investors strikes a balance between reinvesting profits for growth and paying dividends to shareholders.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading data...
Worst Drawdowns
The table below displays the maximum drawdowns of the Tekla Life Sciences Investors. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Tekla Life Sciences Investors was 61.69%, occurring on Oct 9, 2002. Recovery took 2340 trading sessions.
The current Tekla Life Sciences Investors drawdown is 15.94%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -61.69% | Feb 22, 2000 | 661 | Oct 9, 2002 | 2340 | Jan 25, 2012 | 3001 |
| -48.41% | Dec 10, 1992 | 506 | Dec 9, 1994 | 286 | Jan 29, 1996 | 792 |
| -45.17% | Jul 24, 2015 | 140 | Feb 11, 2016 | 1207 | Nov 27, 2020 | 1347 |
| -40.7% | Oct 8, 1997 | 253 | Oct 8, 1998 | 219 | Aug 23, 1999 | 472 |
| -38.86% | Aug 26, 2021 | 546 | Oct 27, 2023 | — | — | — |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading data...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Tekla Life Sciences Investors over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of Tekla Life Sciences Investors, comparing actual results with analytics estimates.
Valuation
The Valuation section provides an overview of how Tekla Life Sciences Investors is priced in the market compared to other companies in the Asset Management industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for HQL, comparing it with other companies in the Asset Management industry. Currently, HQL has a P/E ratio of 4.1. This P/E ratio is considered low compared to industry peers, which may suggest that the stock is undervalued or that the company has weaker growth prospects.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for HQL compared to other companies in the Asset Management industry. HQL currently has a PEG ratio of 0.0. This PEG ratio is low compared to industry peers, which could indicate the stock is undervalued relative to its expected growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for HQL relative to other companies in the Asset Management industry. Currently, HQL has a P/S ratio of 87.1. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for HQL in comparison with other companies in the Asset Management industry. Currently, HQL has a P/B value of 0.7. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |